Deutsche Version Deutsche Version
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
cepii_hygiene_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
  • Health-related issues
  • Teaching
  • Research
  • News data
 
hai /
 
Subnavigation

News

 

Oct. 11, 2021: Research for our drinking water

The Inter-University Cooperation Center for Water and Health (ICC Water & Health), in which Regina Sommer and Alexander Kirschner from our institute as well as the Vienna University of Technology and the Karl Landsteiner Private...more

 

Oct. 1, 2021: Trend magazine elected René Platzer, BSc MSc PhD as its next generation top researcher

To the press release more

 

Sept. 17, 2021: 'EFIS Best Poster Award'

Congratulations! Philipp Schatzlmaier, PostDoc at the Molecular Immunology Unit (HAI), won the 'EFIS Best Poster Award' at the 6th European Congress of Immunology, taking place September 1st to 4th. He was selected as one of...more

 

Sept. 14, 2021: Venugopal Gudipati was selected to give a talk in the Bright Sparks session at the European Congress of Immunology (ECI) 2021.

At the 6th European Congress of Immunology, held online from September 1 – 4, 2021, Venugopal Gudipati (HAI) from the Institute for Hygiene and Applied Immunology (HAI), was selected as one of the 24 Bright Sparks out of the...more

 

Sept. 3, 2021: Water hygiene department

is now the test center of the Austrian Association for Gas and Water ("ÖVGW")more

 

August 2, 2021: MedUni Wien "Researcher of the Month" August 2021, René Platzer, BSc MSc PhD

The “Researcher of the Month” jury gives the award for this month to René Platzer on the occasion of the work published in the top journal “Nature Communications” (IF 13.610) „Unscrambling fluorophore blinking for comprehensive...more

 

Poster price at the PhD Symposium 2021

Congratulation to Dr. Romana Klasinc and MSc. Carmen Rehm for their Poster price!more

 

MedUni Wien Researcher of the month, Mai 2021, Dr. Venugopal Gudipati

Inefficient CAR-proximal signaling blunts antigen detection.more

 

Honuring with the "Ehrennadel der Medizinischen Universität Wien"

On Friday , 2nd of October 2020 Prof. Dr. Hannes Stockinger and Univ. Prof. Dr. Gerhard Zalbinger were honoured by the Rector for their yearlong engagement and remarkable achievements for the Medical University with the...more

 

MedUni Wien "Researcher of the month", Juli 2020: Dr.in Sílvia Cervero-Aragó

Dr.in Sílvia Cervero-Aragó What are legionella bacteria, why can they become a problem and what can be done to prevent them from spreading? next...more

 

Empfehlungen zur Auswahl von Desinfektionsmitteln in Einrichtungen des Gesundheitswesens

Von Assoc. Prof. Dr. Miranda Suchomel, Institut für Hygiene und Angewandte Immunologiemore

 

Wie schütze ich mich am besten vor einer Ansteckung mit dem neuartigen Coronavirus SARS-CoV-2

Da noch keine Schutzimpfungen gegen SARS-CoV-2 existieren, stehen im Moment vor allem Hygienemaßnahmen zur Infektionsprävention im Vordergrund. more

 

Hannes Stockinger honored with Karl Landsteiner-Medal

At the annual meeting of the Austrian Society for Allergology and Immunology (ÖGAI) in Graz, Hannes Stockinger received the Karl Landsteiner-Medal for his merits for immunology, the highest immunological distinction awarded by...more

 

Markus Kraller wins Best Presentation Prize at Medical Postgraduate Conference

At the 16th International Medical Postgraduate Conference, held from 21 - 22 November 2019 in Hradec Králové, Czech Republic, Markus Kraller was awarded a Best Presentation Prizemore

 

Doctoral thesis completed: René Platzer

René Platzer, MSc, PhD – Molecular Immunology Unit – completed his doctoral thesis.more

 

Sílvia Cervero-Aragó wins Forum Water Hygiene Award

The Forum Water Hygiene awards the Science Prize 2018/19 for our latest work on the relevance of VBNC (viable but nonculturable) Legionella, which was recently published in the number 1 journal in the water sector "Water...more

 

Great success of the 20th symposium of the IWA Specialist Group Health-Related Water Microbiology in Vienna

The 20th symposium of the IWA Specialist Group Health-Related Water Microbiology, organized by ICC Water & Health and the Austrian Society for Hygiene, Microbiology and Preventive Medicine in Vienna (September 15–20, 2019, Campus...more

 

Great success for the 11th EFIS-EJI South Eastern European Immunology School (SEEIS2019)

At this year's summer school, held from 27 – 30 September 2019 in Pristina, Kosovo, 65 participants from 15 countries, especially from Eastern Europe, could benefit from lectures and workshops in basic and clinical immunology.more

 

Best Presentation Prizes for Alexandra-Cristina Petre, Michael Reiter and Anna-Margarita Schötta at the 10th Center's Retreat

At the 10th Retreat of the Center, held on September 24, 2019, 74 projects were presented as short presentations and posters.more

 

Microbiological survey of the Danube: no critical levels were measured in Austria

As part of the microbiological research program Joint Danube Survey 4, Assoc. Prof. Alexander Kirschner – with the Interuniversity Cooperation Center Water & Health – analyzed the Danube water for fecal loads.more

 
Displaying results 1 to 20 out of 101
<< First < Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next > Last >>
 
Inhaltsbereich

EU Framework Programme Horizon 2020 supports project of Hannes Stockinger, Gerold Stanek and Mateusz Markowicz

The European Union has granted almost € 2 million to an international consortium that will bring a novel Lyme Borreliosis test to market. The project is led by Innatoss Laboratories from the Netherlands, and combines knowledge from Austria, Germany and the Netherlands. The team will finalize a break-through innovation for Lyme Borreliosis, making early diagnosis and timely treatment possible.

In total € 1.9 million have been granted to the ID-LYME project by the Horizon 2020 Fast Track to Innovation scheme, a part of the EU research and innovation program. The full consortium consists of the Medical University of Vienna (AU), DIARECT AG (DE), npk design and Innatoss Laboratories (NL). The ID-Lyme project is based on a proof of concept study and pre-clinical work performed by Innatoss. Their technology exploits the biomarker production of T cells to detect Lyme Borreliosis as early and distinct as possible.

Lyme-Borrelien im Dunkelfeld, © HAI

Lyme Borreliosis, also known as Lyme disease, is one of the most frequent tick-borne infectious diseases worldwide with over 200,000 new infections each year in Western Europe alone. Treatments with antibiotics are most effective early after onset of the disease. If left untreated however, the infection can spread to the joints, heart and nervous system, causing severe complications. Timely treatment would reduce the impact of Lyme Borreliosis on people’s lives tremendously, as well as the associated healthcare costs, now estimated to be 660 million euros per year in the EU alone.

Project leader and CEO of Innatoss Laboratories Dr. Anja Garritsen explains the goal of ID-Lyme: “The development of a new type of accurate diagnostic test for Lyme Borreliosis is of utmost importance. Patients who do not have the typical Lyme Borreliosis symptoms, including the well-known red ring or erythema migrans, around the bite of the tick, are left untreated. Our T cell-based test can be employed almost immediately after tick detection and therefore will be an important addition to the diagnosis of Lyme Borreliosis.”

Prof. Dr. Gerold Stanek from the Medical University of Vienna is a key opinion leader on Lyme Borreliosis and part of the consortium. The second key scientist of the Vienna team is Prof. Dr. Hannes Stockinger, a profound immunologist with extensive experience in T-cells research. The team is convinced that by analyzing effector T cells, which precede the antibody response, and long-persisting circulating memory T cells, it will be possible, in contrast to the current tests, to diagnose Borrelia infections much earlier and to distinguish latent and chronic infections.

npk design from Leiden will tackle a logistical challenge related to cellular testing; the required incubation of blood soon after withdrawal. Wolfram Peters, CEO of npk design explains: “A dedicated combination of tools and workflow will be developed to ensure correct treatment of the blood samples involved. The consortium will work in close cooperation with users in laboratories across the EU to enable smooth implementation of this new Lyme test in their day-to day practice.”

The high quality antigens that are required for an accurate and reproducible test are manufactured by DIARECT AG from Freiburg, Germany. Diarect has been supplying antigens for autoimmune, infectious disease and allergy diagnostics to kit manufacturers since 1998. “In the past 18 years we have sold antigens that have been incorporated in over 1 billion blood tests world wide”, states Dr. Heinz Haubruck, co-founder and CEO of DIARECT. “With our experience and expertise in protein expression and purification, we are pleased to be a part of this consortium and assist in bringing this novel diagnostic test to market.”

The ID-Lyme project will run for 3 years and result in market launch of the new cellular test in 2019. Other companies, medical centers, diagnostic laboratories and patient organizations will be involved during the whole development period.

Image: Lyme borreliae visualized by dark field microscopy. © Institute for Hygiene and Applied Immunology

 

 

02.08.2016

back to: Institute for Hygiene and Applied Immunology
 
 
Drucken
 

Quick Links

 
-- Head of Institute/ Secretarial office
-- Test results and sample retrieval
-- News Archive
-- Events
-- Intranet Login
-- Jobs
 
 

Featured

 
 
 
 
 
 
 
© MedUni Wien  | 
 Publishing information | Terms of use | Data Protection | Accessibility |Contact